Activity of the Oral Neuraminidase Inhibitor A-322278 against the Oseltamivir-Resistant H274Y (A/H1N1) Influenza Virus Mutant in Mice

Antimicrobial Agents and Chemotherapy
2009.0

Abstract

The new oral neuraminidase (NA) inhibitor A-322278 was evaluated in mice infected with influenza A/H1N1 wild-type virus or the oseltamivir-resistant (H274Y mutant) virus. A-322278 decreased mortality rates and lung virus titers significantly more than oseltamivir in mice infected with the NA H274Y mutant when therapy was started 4 h before or even 48 h after infection.

Knowledge Graph

Similar Paper

Activity of the Oral Neuraminidase Inhibitor A-322278 against the Oseltamivir-Resistant H274Y (A/H1N1) Influenza Virus Mutant in Mice
Antimicrobial Agents and Chemotherapy 2009.0
Prophylactic Activity of Intramuscular Peramivir in Mice Infected with a Recombinant Influenza A/WSN/33 (H1N1) Virus Containing the H274Y Neuraminidase Mutation
Antimicrobial Agents and Chemotherapy 2010.0
Discovery of a non-zwitterionic oseltamivir analogue as a potent influenza a neuraminidase inhibitor
European Journal of Medicinal Chemistry 2020.0
In Vitro Generation of Neuraminidase Inhibitor Resistance in A(H5N1) Influenza Viruses
Antimicrobial Agents and Chemotherapy 2009.0
Discovery of acylguanidine oseltamivir carboxylate derivatives as potent neuraminidase inhibitors
Bioorganic & Medicinal Chemistry 2017.0
Structure-Based Optimization of N-Substituted Oseltamivir Derivatives as Potent Anti-Influenza A Virus Agents with Significantly Improved Potency against Oseltamivir-Resistant N1-H274Y Variant
Journal of Medicinal Chemistry 2018.0
Discovery of hydrazide-containing oseltamivir analogues as potent inhibitors of influenza A neuraminidase
European Journal of Medicinal Chemistry 2021.0
1,2,3-Triazolyl-4-oxoquinolines: A feasible beginning for promising chemical structures to inhibit oseltamivir-resistant influenza A and B viruses
Bioorganic & Medicinal Chemistry 2015.0
Development of Oseltamivir Phosphonate Congeners as Anti-influenza Agents
Journal of Medicinal Chemistry 2012.0
Assessment of Pandemic and Seasonal Influenza A (H1N1) Virus Susceptibility to Neuraminidase Inhibitors in Three Enzyme Activity Inhibition Assays
Antimicrobial Agents and Chemotherapy 2010.0